PHH, BYAH Deadline: Rosen Law Firm Urges Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their RightsBusiness Wire · Sep 24, 2026
PHH, BYAH DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAHNewsfile Corp · Sep 24, 2026
PHH, BYAH DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAHGlobeNewsWire · Sep 23, 2026
PHH, BYAH DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAHNewsfile Corp · Sep 22, 2026
Portnoy Law Firm Announces Class Action on Behalf of Park Ha Biological Technology Co., Inc. InvestorsGlobeNewsWire · Sep 22, 2026
PHH, BYAH Deadline: PHH, BYAH Investors with Losses in Excess of $100K Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities LawsuitPRNewsWire · Sep 21, 2026Park Ha Biological Technology Co., Ltd., an investment holding firm, is primarily engaged in the creation and development of skincare products within the People's Republic of China. The company's operations are divided into two core areas: direct product sales and a franchise service model. Under its own 'Park Ha' brand, the company offers a comprehensive selection of skincare solutions.